🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of lurbine...
Status
Recruiting
Location
Valkyrie Clinical Trials, Inc.
Start Date
2026-08-30
Trial ID
NCT07459634
Treatments Being Tested
Multicenter, open-label, randomized, controlled phase III clinical trial to...
Status
Completed
Location
Ironwood Cancer & Research Centers
Start Date
2022-07-22
Trial ID
NCT05153239
Treatments Being Tested
Prospective, open-label, two-way crossover, phase Ib drug-drug interaction ...
Status
Completed
Location
Fundacion Jimenez Diaz
Start Date
2020-10-07
Trial ID
NCT05063318
Treatments Being Tested
This exploratory trial aims to determine if it is safe to use radiotherapy ...
Status
Active Not Recruiting
Location
National Cancer Center/Cancer Hospital
Start Date
2025-12-31
Trial ID
NCT06501976
Treatments Being Tested
This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expa...
Status
Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2023-09-05
Trial ID
NCT05652686
Prospective, open-label, dose-ranging, uncontrolled phase I/II study of Lur...
Status
Completed
Location
Sarcoma Oncology Center
Start Date
2016-05-06
Trial ID
NCT02611024
Treatments Being Tested
This is a prospective, open-label, uncontrolled and multicenter phase I/II ...
Status
Completed
Location
Hospital Vall D´Hebrón
Start Date
2020-09-21
Trial ID
NCT04358237
Treatments Being Tested
This phase Ib/II trial studies best dose and side effects of lurbinectedin ...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2021-09-15
Trial ID
NCT05042934
Treatments Being Tested
A clinical study of lurbinectedin(PM01183) alone or in combination with gem...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-11
Trial ID
NCT01951157
Treatments Being Tested
The goal of this clinical study is to learn more about the study drug sacit...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-04-04
Trial ID
NCT06801834